Clinical Research Directory

Key Inclusion Criteria: 1. Participants received VGR-R01 administration in the VGR-R01-001 or VGR-R01-101 studies. 2. Able to provide informed consent and comply with requirements of the study; 3. Hand Motion ≤ BCVA ≤ 75 ETDRS letters in the second treated eye. Key Exclusion Criteria: 1. Have insufficient viable retinal photoreceptor cells based on investigator's decision; 2. Have current ocular or periocular infections, or endophthalmitis; 3. Have any significant ocular disease/disorder other than BCD, including age-related macular degeneration, diabetic retinopathy, optic neuropathy, significant lens opacity, glaucoma, uveitis, retinal detachment, etc; 4. Have intraocular surgery history except cataract surgery in the study eye; 5. Have or potentially require of systemic medications that may cause eye injure; 6. Have contraindications for corticosteroids or immunosuppressant; 7. Abnormal coagulation function or other clinically significant abnormal laboratory results; 8. Have malignancies or history of malignancies; 9. History of immunodeficiency (acquired or congenital); Other protocol defined Inclusion/Exclusion criteria may apply.